VENTURE CREATION
Build from the frontier
Stage-by-stage venture building across AI × Bio and applied AI — from founder sourcing through commercialization and fundraising.
Explore pipeline →
CAI STUDIO
Building AI ventures across global innovation ecosystems.
CAI works with founders, researchers, and technology companies to transform frontier AI opportunities into scalable ventures — from venture creation and strategic partnerships to global expansion and capital.
WHY CAI
Built at the intersection of research, capital, industry, and global markets.
CAI is not a consulting desk or a passive network. It is a cross-border venture platform — identifying, accelerating, and scaling AI ventures where Canada, Asia, and Silicon Valley innovation ecosystems converge.
RESEARCH
Universities, labs, and clinical networks
CAPITAL
Strategic investors and cross-border finance
INDUSTRY
Corporates, hubs, and deployment corridors
GLOBAL MARKETS
North America, Asia, and Silicon Valley
Canada + Asia + Silicon Valley
STUDIO
Four pathways into CAI.
CAI Studio is not a consulting desk. It is where ecosystem relationships, venture creation, and strategic capital come together — for founders, companies, and partners building across Canada, Asia, and global markets.
FOR FOUNDERS
Researchers & technical founders
Venture building, ecosystem access, fundraising support, and global expansion for scientists, researchers, clinicians, and technical founders.
Learn more →
FOR PARTNERS
Strategic partners
Investors, family offices, corporates, universities, governments, and ecosystem organizations co-building with CAI Studio.
Learn more →
FOR COMPANIES
Strategic partners
Global ecosystem access, commercialization pathways, and strategic capital for AI and technology leaders expanding across borders.
Learn more →
THESIS
AI is moving from models to execution. The founders best positioned to build in this decade are rarely full-time operators from day one — they're scientists, clinicians, and researchers with an insight no generalist team could arrive at alone. CAI's job is to turn that insight into a company.
CAI BIO VENTURE STUDIO
AI × Biotech, built stage by stage.
A four-stage pipeline that carries a scientific insight from first conversation to a funded company — spanning Toronto's hospital and research network to BioBAY Suzhou.
STAGE 01
Find Founders
Sourced from research labs, hospital networks, and clinical practice — not from the standard pitch-deck pipeline.
STAGE 02
Evaluate Opportunities
A structured intake and scoring process, entered through a Diagnostic Sprint that stress-tests the scientific and commercial thesis before any commitment is made.
STAGE 03
Build Companies
A Fractional Science Advisory Layer supports the founding team on regulatory strategy, clinical pathway, and go-to-market — without requiring a full executive hire on day one.
STAGE 04
Fundraise Capital
Introductions to investors across North America and Asia, sequenced to match the company's regulatory and clinical milestones.
CAI VENTURE STUDIO — APPLIED AI
Infrastructure and agents, built separately from Bio.
Applied-AI ventures — AI agents, enterprise AI, and AI infrastructure — sit in their own vertical. The diligence bar for a clinical product and a software product isn't the same, so we don't run them through the same process.
Building now: an active pipeline across AI infrastructure and applied biotech, currently under evaluation. Named companies are shared directly with partners and capital — not published here while diligence is in progress.
SECTOR
AI Infrastructure
SECTOR
AI Agents
SECTOR
AI × Biotech
SECTOR
Digital Assets
"The best way to predict the future is to create it."— Peter Drucker
Building at the frontier of AI?
Founders, strategic partners, and capital — start with a private conversation.